Skip to main content
HR 2223 110th Congress House Health Congressional reporting requirements Drugs Environmental Protection Environmental assessment Governmental investigations Pharmacies Refuse and refuse disposal

To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug…

Show full title

To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.

Introduced: May 8, 2007 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 110th Congress ended
It never became law before the 110th Congress (2007–2008) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
May 8, 2007
Referred to the Subcommittee on Health.
May 8, 2007
Referred to the House Committee on Energy and Commerce.
May 8, 2007
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Requires the Director of the Office of National Drug Control Policy to study and report to Congress on prescription drug disposal programs in which individuals return unused prescription drugs to pharmacies or other locations, focusing on certain issues including: (1) best practices of such programs; (2) affects of such programs on pharmacies; and (3) training and infrastructure needed to ensure the success of such programs.

Requires the Administrator of the Environmental Protection Agency (EPA) to conduct a study identifying the environmental impacts of current prescription drug disposal programs and methods.

What's happening now May 8, 2007

Referred to the Subcommittee on Health.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Republican 1
R
Calvert, Ken
California · Feb 12, 2008
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2223: To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.. 110th Congress. Open America. https://openamerica.io/bill/110-HR-2223/
MLA
"H.R. 2223: To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.." 110th Congress, 2026, Open America, https://openamerica.io/bill/110-HR-2223/.
Bluebook (legal)
H.R. 2223, 110th Cong. (2026), https://openamerica.io/bill/110-HR-2223/.
Markdown link
[H.R. 2223: To direct the Director of the Office of National Drug Control Policy, in consultation with the Attorney General and the Secretary of Health and Human Services, to conduct a study on prescription drug take-back programs, and for other purposes.](https://openamerica.io/bill/110-HR-2223/)
Report a problem